Literature DB >> 31722908

Colorectal cancer screening for patients with a family history of colorectal cancer or adenomas.

Anna N Wilkinson1, David Lieberman2, Grigorios I Leontiadis3, Frances Tse4, Alan N Barkun5, Ahmed Abou-Setta6, John K Marshall7, Jewel Samadder8, Harminder Singh9, Jennifer J Telford10, Jill Tinmouth11, Desmond Leddin12.   

Abstract

OBJECTIVE: To review and summarize the recently developed Canadian Association of Gastroenterology screening recommendations for patients with a family history of colorectal cancer (CRC) or adenoma from a family medicine perspective. QUALITY OF EVIDENCE: A systematic review and meta-analysis was performed to synthesize knowledge regarding family history and CRC. The Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE were searched with the following MeSH terms: colorectal cancers or neoplasms, screen or screening or surveillance, and family or family history. Known hereditary syndromes were excluded. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to establish certainty in reviewed evidence. Most recommendations are conditional recommendations with very low-quality evidence. MAIN MESSAGE: Individuals who have 1 first-degree relative (FDR) with CRC or an advanced adenoma diagnosed at any age are recommended to undergo colonoscopy every 5 to 10 years starting at age 40 to 50 years or 10 years younger than the age at diagnosis of the FDR, although fecal immunochemical testing at an interval of every 1 to 2 years can be used. Individuals with FDRs with non-advanced adenomas or a history of CRC in second-degree relatives should be screened according to average-risk guidelines. Lifestyle modification can statistically significantly decrease risk of CRC and should be considered in all patients.
CONCLUSION: These guidelines acknowledge the many factors that can increase an individual's risk of developing CRC and allow for judgment to be employed depending on the clinical scenario. Lifestyle advice already given to patients for weight, blood pressure, and heart disease management will reduce the risk of CRC if implemented, and this combined with more targeted screening for higher-risk individuals will hopefully be successful in decreasing CRC mortality in Canada. Copyright© the College of Family Physicians of Canada.

Entities:  

Year:  2019        PMID: 31722908      PMCID: PMC6853346     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  24 in total

1.  A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.

Authors:  Scott D Ramsey; Janneke Wilschut; Rob Boer; Marjolein van Ballegooijen
Journal:  Am J Gastroenterol       Date:  2010-05-11       Impact factor: 10.864

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  Impact of a family history of colorectal cancer on the prevalence of advanced neoplasia at colonoscopy in 4,967 asymptomatic patients.

Authors:  Franklin C Tsai; Williamson B Strum
Journal:  Dig Dis Sci       Date:  2011-12-20       Impact factor: 3.199

4.  Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.

Authors:  Desmond Leddin; David A Lieberman; Frances Tse; Alan N Barkun; Ahmed M Abou-Setta; John K Marshall; N Jewel Samadder; Harminder Singh; Jennifer J Telford; Jill Tinmouth; Anna N Wilkinson; Grigorios I Leontiadis
Journal:  Gastroenterology       Date:  2018-08-16       Impact factor: 22.682

5.  Colorectal cancer surveillance after index colonoscopy: guidance from the Canadian Association of Gastroenterology.

Authors:  Desmond Leddin; Robert Enns; Robert Hilsden; Carlo A Fallone; Linda Rabeneck; Daniel C Sadowski; Harminder Singh
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

6.  Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice.

Authors:  Linda Rabeneck; Lawrence F Paszat; Robert J Hilsden; Refik Saskin; Des Leddin; Eva Grunfeld; Elaine Wai; Meredith Goldwasser; Rinku Sutradhar; Therese A Stukel
Journal:  Gastroenterology       Date:  2008-09-13       Impact factor: 22.682

7.  Colonoscopic surveillance of patients with a family history of colon cancer and a history of normal colonoscopy: is a five-year interval between colonoscopies appropriate?

Authors:  Philip S Schoenfeld; Roger Keith Fincher
Journal:  Clin Gastroenterol Hepatol       Date:  2003-07       Impact factor: 11.382

Review 8.  Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Authors:  Jan T Lowery; Dennis J Ahnen; Paul C Schroy; Heather Hampel; Nancy Baxter; C Richard Boland; Randall W Burt; Lynn Butterly; Megan Doerr; Mary Doroshenk; W Gregory Feero; Nora Henrikson; Uri Ladabaum; David Lieberman; Elizabeth G McFarland; Susan K Peterson; Martha Raymond; N Jewel Samadder; Sapna Syngal; Thomas K Weber; Ann G Zauber; Robert Smith
Journal:  Cancer       Date:  2016-06-03       Impact factor: 6.860

9.  Meta-analyses of colorectal cancer risk factors.

Authors:  Constance M Johnson; Caimiao Wei; Joe E Ensor; Derek J Smolenski; Christopher I Amos; Bernard Levin; Donald A Berry
Journal:  Cancer Causes Control       Date:  2013-04-06       Impact factor: 2.506

10.  Cost-effectiveness of family history-based colorectal cancer screening in Australia.

Authors:  Driss A Ouakrim; Alex Boussioutas; Trevor Lockett; John L Hopper; Mark A Jenkins
Journal:  BMC Cancer       Date:  2014-04-16       Impact factor: 4.430

View more
  4 in total

1. 

Authors:  Geneviève Chaput; M Elisabeth Del Giudice; Ed Kucharski
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275

2.  Cancer screening in Canada: What's in, what's out, what's coming.

Authors:  Genevieve Chaput; M Elisabeth Del Giudice; Ed Kucharski
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275

Review 3.  A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis.

Authors:  Tomasz Sawicki; Monika Ruszkowska; Anna Danielewicz; Ewa Niedźwiedzka; Tomasz Arłukowicz; Katarzyna E Przybyłowicz
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

4.  Uptake and Short-term Outcomes of High-risk Screening Colonoscopy Billing Codes: A Population-based Study Among Young Adults.

Authors:  Lawrence Paszat; Rinku Sutradhar; Jin Luo; Jill Tinmouth; Linda Rabeneck; Nancy N Baxter
Journal:  J Can Assoc Gastroenterol       Date:  2021-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.